PLSI — Phoenix Life Sciences International Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.06m
Annual balance sheet for Phoenix Life Sciences International, fiscal year end - February 28th, USD millions except per share, conversion factor applied.
R2015 February 28th | C2016 February 29th | 2017 February 28th | 2018 February 28th | 2019 February 28th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-Q | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.009 | 0.008 | 0.001 | 0.001 | 0.202 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.26 | 0.249 | 0.236 | 0.236 | 0 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1.62 | 0.257 | 0.237 | 0.236 | 2.37 |
Net Property, Plant And Equipment | — | — | — | — | 8.77 |
Other Long Term Assets | |||||
Total Assets | 1.62 | 0.257 | 0.237 | 0.236 | 11.4 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.63 | 0.78 | 0.796 | 0.796 | 1.35 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.05 | 1.37 | 1.6 | 1.6 | 1.35 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.422 | -1.11 | -1.36 | -1.36 | 10.1 |
Total Liabilities & Shareholders' Equity | 1.62 | 0.257 | 0.237 | 0.236 | 11.4 |
Total Common Shares Outstanding |